Search Results

Oseltamivir 50mg  | 98.6%

APEXBIO TECHNOLOGY LLC

inhibitor of influenza neuraminidase Microbiology & Virology|NA

More Information Supplier Page

×

Oseltamivir

Oseltamivir 10mg  | 98.6%

APEXBIO TECHNOLOGY LLC

inhibitor of influenza neuraminidase Microbiology & Virology|NA

More Information Supplier Page

×

Oseltamivir

Oseltamivir 10mM (in 1mL DMSO)  | 98.6%

APEXBIO TECHNOLOGY LLC

inhibitor of influenza neuraminidase Microbiology & Virology|NA

More Information Supplier Page

×

Oseltamivir

Orteronel 25mg  | 98%

APEXBIO TECHNOLOGY LLC

For castration-resistant prostate cancer, clinical candidate GPCR/G protein|17,20-lyase

More Information Supplier Page

×

Orteronel

Orteronel 10mg  | 98%

APEXBIO TECHNOLOGY LLC

For castration-resistant prostate cancer, clinical candidate GPCR/G protein|17,20-lyase

More Information Supplier Page

×

Orteronel

Olprinone Hydrochloride 500mg  | 98.85%

APEXBIO TECHNOLOGY LLC

Phosphodiesterase 3 (PDE3) inhibitor, selective Metabolism|PDE

More Information Supplier Page

×

Olprinone Hydrochloride

ONO-AE3-208 5mg  | 98.37%

APEXBIO TECHNOLOGY LLC

EP4 receptor antagonist,high affinity and selective GPCR/G protein|EP4 Receptor

More Information Supplier Page

×

ONO-AE3-208

ONO-AE3-208 10mg  | 98.37%

APEXBIO TECHNOLOGY LLC

EP4 receptor antagonist,high affinity and selective GPCR/G protein|EP4 Receptor

More Information Supplier Page

×

ONO-AE3-208

ONO-AE3-208 25mg  | 98.37%

APEXBIO TECHNOLOGY LLC

EP4 receptor antagonist,high affinity and selective GPCR/G protein|EP4 Receptor

More Information Supplier Page

×

ONO-AE3-208

Orteronel 5mg  | 98%

APEXBIO TECHNOLOGY LLC

For castration-resistant prostate cancer, clinical candidate GPCR/G protein|17,20-lyase

More Information Supplier Page

×

Orteronel